Patent & IP news for February 2, 2016

10 Key IP Strategy Insights for Innovative Companies for 2016 and Beyond from ipassetmaximizerblog.com

As 2016 begins, I am entering my 8th year(!) of writing about IP strategy insights from a business value creation perspective, both here on my IPMaximizerBlog.com and, more recently, on LinkedIn. While there were ...

Share via E–mail | Twitter | Facebook

US trade secrets legislation on the way to full Senate consideration from ipkitten.blogspot.com

Like the California sky in January,
will the future be bright
for the DTSA as it floats towards
full Senate consideration?Last Thursday, the US Senate Committee on the Judiciary reported the proposed Defend Trade ...

Share via E–mail | Twitter | Facebook

German Federal Patent Court (partially) invalidates 80% of litigated patents from ipkitten.blogspot.com

Patent grave yard?A study by Hess, Müller-Stoy and Wintermeier provides an interesting empirical look at the invalidation rate before the German Federal Patent Court and German Federal Court of Justice. Based on data from ...

Share via E–mail | Twitter | Facebook

Paice Licenses Hybrid Vehicle Patents to More Big Automakers from www.greenpatentblog.com

In another big success for Paice, the hybrid vehicle technology company recently reached an agreement to license all of its tech to Hyundai and Kia. This comes after a Baltimore jury found that the Korean ...

Share via E–mail | Twitter | Facebook

Inquiry as to damages: no longer a rare avis? from ipkitten.blogspot.com


Brian Whitehead, at Kempner & Partners, has provided an edifying summary regarding the increased feasibility of electing an inquiry as to damages in connection with patent litigation.

"AP Racing (a subsidiary of a leading motorsport and ...

Share via E–mail | Twitter | Facebook

Advanced Marketing Systems, LLC v. CVS Pharmacy (E.D. Tex. 2016) from www.patentdocs.org

By Michael Borella -- In February 2015, Advanced Marketing Systems (AMS) sued a number of defendants, alleging infringement of various claims of U.S. Patent Nos. 8,219,445, 8,370,199, and 8,538,805 ...

Share via E–mail | Twitter | Facebook

Allegation that Jury Reached “Quick Compromise” No Basis for Overturning $15.7 Million Verdict from docketreport.blogspot.com

The court denied defendant's renewed motion for judgment as a matter of law that the jury's damages finding was insufficient and rejected defendant's argument that the jury reached a quick compromise award ...

Share via E–mail | Twitter | Facebook

Increasing Shortages Of Medicines Discussed At WHO, To Be Continued In May from www.ip-watch.org

There is an increasing shortage of medicines in the world, in particular in developing countries, but not only there, World Health Organization members said in last week’s Executive Board meeting. Discussions are ongoing on ...

Share via E–mail | Twitter | Facebook

Last Chance Meeting To Agree On How WHO Engages With Non-Government Actors In April from www.ip-watch.org

World Health Organization members last week agreed to meet for a final session in April to discuss the framework regulating the engagement of the organisation with “non-state actors,” such as non-governmental and philanthropy organisations, and ...

Share via E–mail | Twitter | Facebook

@Mizzou: Administrative Patent & Trademark Hearings & Symposium from patentlyo.com

Save the Date: On March 1, 2016, the University of Missouri School of Law and our Center for Intellectual Property and Entrepreneurship will host an event that we’re generically calling Patent and Trademark Administrative ...

Share via E–mail | Twitter | Facebook

More on Edison and the light bulb and ethical norms in intellectual property scholarship from ipbiz.blogspot.com

As a followup to the IPBiz post Ethical norms in "intellectual property" scholarship?, which pertained to an open letter expressing concern over an influx of large contributions from corporate and private actors who have an ...

Share via E–mail | Twitter | Facebook

Columbia University gets remand on infringement assertions as to U.S. Patent No. 8,074,115 and U.S. Patent No. 8,601,322 from ipbiz.blogspot.com




Note how the Teva case is cited:


Claim construction is ultimately a question of law
that this court reviews de novo. Teva Pharm. USA, Inc. v.
Sandoz, Inc., 135 S. Ct. 831, 839 (2015). The ...

Share via E–mail | Twitter | Facebook

The Conversation: Netflix’s VPN Ban Proves We Need To Develop A Global, Legal Digital Marketplace from www.ip-watch.org

In mid-January, Netflix announced a ban on the use of proxies, unblockers, and virtual private networks (VPNs)—all technical work-arounds to view movies and TV programs unavailable in the subscriber’s country. This announcement coincided ...

Share via E–mail | Twitter | Facebook